See All Slides - tctmd.com

Slides

Presentation TCT 2025

TCT 1075: Interventional readiness during environmental extremes: A National Infarction Register based analysis from Central Europe

Presenter: Péter Süveges

October 26, 2025

Presentation TCT 2025

TCT 178: Use of the AGENT Paclitaxel-Coated Balloon in the United States Shortly After FDA Approval: Early Results from the AGENT Post-Approval Study

Presenter: Christina Lalani

October 26, 2025

Presentation TCT 2025

TCT 1730: Rotational Atherectomy in a Patient With ST-Segment Elevation Myocardial Infarction: From Relative Contraindication to Salvation

Presenter: Michail Papafaklis

October 26, 2025

Presentation TCT 2025

TCT 640: Diabetes, Glucose Dysregulation, and Inflammatory Biomarkers as Predictors of Mortality and Adverse Events Following Transcatheter Aortic Valve Implantation: A Systematic Review and Meta-analysis

Presenter: Mahsa Rezasoltani

October 26, 2025

Presentation TCT 2025

TCT 180: Paclitaxel-Coated Balloon versus Uncoated Balloon for Coronary In-Stent Restenosis in Patients with Acute Coronary Syndromes: A Subanalysis of the AGENT IDE Trial

Presenter: Neal S. Kleiman

October 26, 2025

Presentation TCT 2025

TCT 952: Evaluation of the Effect of Hysterectomy in Women Age ≤50 on Post Percutaneous Coronary Intervention Outcomes Through a Retrospective Cohort Study

Presenter: Khaled Elnaggar

October 26, 2025

Presentation TCT 2025

TCT 643: Treatment of Aortic Stenosis in Patients with Active Cancer: Lifetime Management Considerations

Presenter: Philipp Kiefer

October 26, 2025

Presentation TCT 2025

TCT 315: Incidence of fenestrated atrial septal defects in patients referred for PFO closure

Presenter: Vandan Upadhyaya

October 26, 2025

Presentation TCT 2025

TCT 340: Procedural Success and Long-Term Outcomes of Percutaneous Coronary Intervention for Chronic Total Occlusion in Small Versus Large Vessels: A Contemporary Single-Center Experience

Presenter: Mangesh Kritya

October 26, 2025

Presentation TCT 2025

TCT 375: Optimizing Treatment for MEDINA 0.0.1 Bifurcation Lesions: A Comparative Evaluation of Drug-Coated Balloons and Drug-Eluting Stents

Presenter: Sunwon Kim

October 26, 2025

Advertisement

Slides

TCT 1075: Interventional readiness during environmental extremes: A National Infarction Register based analysis from Central Europe

TCT 178: Use of the AGENT Paclitaxel-Coated Balloon in the United States Shortly After FDA Approval: Early Results from the AGENT Post-Approval Study

TCT 1730: Rotational Atherectomy in a Patient With ST-Segment Elevation Myocardial Infarction: From Relative Contraindication to Salvation

TCT 640: Diabetes, Glucose Dysregulation, and Inflammatory Biomarkers as Predictors of Mortality and Adverse Events Following Transcatheter Aortic Valve Implantation: A Systematic Review and Meta-analysis

TCT 180: Paclitaxel-Coated Balloon versus Uncoated Balloon for Coronary In-Stent Restenosis in Patients with Acute Coronary Syndromes: A Subanalysis of the AGENT IDE Trial

TCT 952: Evaluation of the Effect of Hysterectomy in Women Age ≤50 on Post Percutaneous Coronary Intervention Outcomes Through a Retrospective Cohort Study

TCT 643: Treatment of Aortic Stenosis in Patients with Active Cancer: Lifetime Management Considerations

TCT 315: Incidence of fenestrated atrial septal defects in patients referred for PFO closure

TCT 340: Procedural Success and Long-Term Outcomes of Percutaneous Coronary Intervention for Chronic Total Occlusion in Small Versus Large Vessels: A Contemporary Single-Center Experience

TCT 375: Optimizing Treatment for MEDINA 0.0.1 Bifurcation Lesions: A Comparative Evaluation of Drug-Coated Balloons and Drug-Eluting Stents

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content